GlyTR™ is an early stage biotech company developing an entirely new class of immunotherapeutic anti-cancer molecules and cells.
GlyTR Therapeutics, Inc.
BioStartup's Score 0 / 50
STOCK CODENon Listed
Address5151 California Ave Ste 150,CA 092617IrvineUnited States
5151 California Ave Ste 150,CA 092617